oral semaglutide versus subcutaneous semaglutide Comparing vs. Injectable Clinical Perspectives on the Use

The protective effect appears strongest in individuals with existing risk factor profiles, particularly those with diabetes and weight loss challenges who face elevated dementia risk from multiple sources

Phelan SM, Bauer KW, Bradley D, Bradley SM, Haller IV, Mundi MS, et al

Probiotics for Gastrointestinal Conditions: A Summary of the Evidence

After continued examination, in the CY 2026 PFS proposed rule, we re-proposed to modify the sixth criterion of the definition of attribution-eligible beneficiary at 414.1305 to include any beneficiary who has received a covered professional service furnished by the eligible clinician for whom we are making the QP determination, beginning with the 2026 QP Performance Period

Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist used to improve blood sugar control in adults with type 2 diabetes